• Invest
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Product Suite
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Product Suite
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Market Movers
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Commodities
    Currency
    Futures & Options
    Derivatives
    Margin Trading
    Events
    Budget 2024
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Fund Expert
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement

Apollo Hospitals’ Q2FY25 Results

Apollo Hospitals’ revenue increased over 15% YoY
  • 07 Nov 2024
Read Full Article >
  • Apollo Hospitals reported a 9.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended Sept (Q2FY25). On a year-on-year (YoY) basis, it witnessed a growth of 15.6%.
  • Its expenses for the quarter were up by 7.9% QoQ and 12.9% YoY.
  • The net profit increased 25.4% QoQ and 59% YoY.
  • The earnings per share (EPS) of Apollo Hospitals stood at 26.3 during Q2FY25.
(₹ crores) Q2FY24 Q1FY25 Q2FY25 QoQ (%) YoY (%)
Total income
4,869
5,123
5,628
9.9%
15.6%
Total expenses
4,494
4,704
5,076
7.9%
12.9%
Profit before tax
379
430
557
29.6%
47.1%
Tax
130
115
162
41.2%
24.2%
Profit after tax
249
316
396
25.4%
59.0%
Earnings per share
16.2
21.2
26.3

Financials:

Revenue: Total Revenue ₹5,589 Crores, up 15% YoY.
EBITDA: ₹816 Crores, up 30% YoY.
Profit after Tax (PAT): ₹379 Crores, up 63% YoY from ₹233 Crores in Q2 FY24.

Management Commentary:

Dr. Prathap C. Reddy, Founder & Chairman of Apollo Hospitals Group:

  • Commitment to Healthcare Access: Apollo Hospitals is dedicated to meeting the evolving healthcare needs of India through investments in Apollo Health and Lifestyle and new multi-specialty hospitals, particularly in critical access regions.
  • Notable Partnership: Recently partnered with the Government of Tripura to provide free heart surgeries for children, emphasizing the goal of accessible healthcare for underserved communities.
  • Advancements in Medical Technology: Introducing innovative treatments like water vapor thermotherapy for prostate care and robotic radiosurgery systems for cancer to make procedures less invasive and improve patient recovery.
  • Investment in Medical Research: Launching a new research academy focused on groundbreaking medical discoveries to shape the future of healthcare and treatments.
  • Mission for the Future: Aiming to expand the reach and impact of healthcare services, ensuring that everyone has access to quality medical care regardless of location. This aligns with Apollo's mission to push the boundaries of healthcare and provide the best medical services.
  • Outlook for FY25: Marked as an exciting time with milestones in extending healthcare impact, reaffirming Apollo's commitment to innovation, safety, and advancing medical science.

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -

N
N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]